ContextVision (0L8Z.L) Stock Analysis & AI Equity Report
ContextVision (0L8Z.L) overview
ContextVision (0L8Z.L) stock analysis and AI equity research. For the latest completed financial year, 2024, ContextVision reported revenue of SEK 131m and operating profit of SEK 29.8m; the year-end share price was 5.50 GBP and market capitalisation was GBP 426m. ContextVision is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get ContextVision's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-12-12. Data will be refreshed during report generation.
About ContextVision
ContextVision AB is a Swedish medical technology software company focused on image analysis and artificial intelligence. It develops proprietary software for image enhancement and interpretation, primarily for ultrasound, X-ray, and MRI equipment. The company serves medical device manufacturers and supports clinical decision-making by improving the quality and reliability of medical imaging.
Generate the ContextVision report
ContextVision is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for ContextVision and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.